PDF herunterladen
CC BY 4.0 · TH Open 2018; 02(02): e131-e138
DOI: 10.1055/s-0038-1641678
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Long-Term Incidence of Venous Thromboembolism in Cancer: The Scandinavian Thrombosis and Cancer Cohort

Inger Lise Gade
1   Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
,
Sigrid K. Brækkan
2   Department of Clinical Medicine, K.G Jebsen Thrombosis Research and Expertise Centre (TREC), University of Tromsø—The Arctic University of Norway, Tromsø, Norway
3   Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway
,
Inger Anne Næss
4   Department of Haematology, Trondheim University Hospital, Trondheim, Norway
,
John-Bjarne Hansen
2   Department of Clinical Medicine, K.G Jebsen Thrombosis Research and Expertise Centre (TREC), University of Tromsø—The Arctic University of Norway, Tromsø, Norway
3   Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway
,
Suzanne C. Cannegieter
5   Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands
,
Frits R. Rosendaal
5   Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands
,
Kim Overvad
6   Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark
7   Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark
,
Kristian Hindberg
2   Department of Clinical Medicine, K.G Jebsen Thrombosis Research and Expertise Centre (TREC), University of Tromsø—The Arctic University of Norway, Tromsø, Norway
,
Jens Hammerstrøm
8   Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway
,
Olga V. Gran
2   Department of Clinical Medicine, K.G Jebsen Thrombosis Research and Expertise Centre (TREC), University of Tromsø—The Arctic University of Norway, Tromsø, Norway
,
Anne Tjønneland
9   Department of Diet, Genes and Environment, Danish Cancer Society Research Center, Copenhagen, Denmark
,
Marianne T. Severinsen
1   Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
10   Department of Haematology, Aalborg University Hospital, Aalborg, Denmark
,
Søren R. Kristensen
1   Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
11   Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark
› Institutsangaben Funding K.G. Jebsen Thrombosis Research and Expertise Center (TREC) received an independent research grant from Stiftelsen Kristian Gerhard Jebsen. Professor S.R. Kristensen received an independent research grant from The Obel Family Foundation and from the Danish Council for Independent Research.
Weitere Informationen

Publikationsverlauf

21. November 2017

19. Februar 2018

Publikationsdatum:
06. April 2018 (online)

   Lizenzen und Reprints

Abstract

The risk of venous thromboembolism (VTE) in patients who survive the first years after a cancer diagnosis after the acute effects of disease and treatment in comparison to a similar background population has been sparsely investigated. The aim of the study was to investigate if incidence rates (IRs) of VTE differed in patients who were alive at least 2 years after a cancer diagnosis without VTE compared with cancer-free references in a population-based cohort study. The study entry was 2 years after a first cancer diagnosis. For each cancer-exposed subject, five reference subjects were identified within the cohort. The IRs were calculated as number of VTEs per 1,000 person years (×10−3 p-y) in total and in distinct cancer types and corresponding reference subjects. Incidence rate ratios (IRRs) were calculated by Poisson's regression. During a mean follow-up of 5.3 years, 110 VTEs occurred among the 7,288 cancer-exposed subjects and 321 VTEs occurred among the 36,297 identified reference subjects. The IR of VTE was higher for cancer-exposed subjects compared with reference subjects, IRs 3.7 × 10−3 p-y, 95% CI: 3.1 to 4.5 and 1.9 × 10−3 p-y, 95% CI: 1.7 to 2.2, respectively. IRs of VTE in most solid cancer types declined to almost the same level as in the reference subjects 2 years after cancer diagnosis, but remained higher in hematological cancers, IRR 4.0, 95% CI: 2.0 to 7.8.

Keywords

cancer - epidemiology - prospective studies - time factors - venous thromboembolism
 

  • References

  • 1 Cohen AT, Katholing A, Rietbrock S, Bamber L, Martinez C. Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study. Thromb Haemost 2017; 117 (01) 57-65
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 2 Walker AJ, Card TR, West J, Crooks C, Grainge MJ. Incidence of venous thromboembolism in patients with cancer - a cohort study using linked United Kingdom databases. Eur J Cancer 2013; 49 (06) 1404-1413
    CrossrefPubMedGoogle Scholar
  • 3 Cronin-Fenton DP, Søndergaard F, Pedersen LA. , et al. Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997-2006. Br J Cancer 2010; 103 (07) 947-953
    CrossrefPubMedGoogle Scholar
  • 4 Blom JW, Vanderschoot JP, Oostindiër MJ, Osanto S, van der Meer FJ, Rosendaal FR. Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study. J Thromb Haemost 2006; 4 (03) 529-535
    CrossrefPubMedGoogle Scholar
  • 5 Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer 2007; 110 (10) 2339-2346
    CrossrefPubMedGoogle Scholar
  • 6 Stein PD, Beemath A, Meyers FA, Skaf E, Sanchez J, Olson RE. Incidence of venous thromboembolism in patients hospitalized with cancer. Am J Med 2006; 119 (01) 60-68
    CrossrefPubMedGoogle Scholar
  • 7 Chew HK, Wun T, Harvey D, Zhou H, White RH. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med 2006; 166 (04) 458-464
    CrossrefPubMedGoogle Scholar
  • 8 Timp JF, Braekkan SK, Versteeg HH, Cannegieter SC. Epidemiology of cancer-associated venous thrombosis. Blood 2013; 122 (10) 1712-1723
    CrossrefPubMedGoogle Scholar
  • 9 Blom JW, Doggen CJ, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 2005; 293 (06) 715-722
    CrossrefPubMedGoogle Scholar
  • 10 Walker AJ, Baldwin DR, Card TR, Powell HA, Hubbard RB, Grainge MJ. Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare data. Br J Cancer 2016; 115 (01) 115-121
    CrossrefPubMedGoogle Scholar
  • 11 Alcalay A, Wun T, Khatri V. , et al. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival. J Clin Oncol 2006; 24 (07) 1112-1118
    CrossrefPubMedGoogle Scholar
  • 12 Walker AJ, West J, Card TR, Crooks C, Kirwan CC, Grainge MJ. When are breast cancer patients at highest risk of venous thromboembolism? A cohort study using English health care data. Blood 2016; 127 (07) 849-857 , quiz 953
    CrossrefPubMedGoogle Scholar
  • 13 Walker AJ, West J, Card TR, Humes DJ, Grainge MJ. Variation in the risk of venous thromboembolism in people with colorectal cancer: a population-based cohort study from England. J Thromb Haemost 2014; 12 (05) 641-649
    CrossrefPubMedGoogle Scholar
  • 14 Brand JS, Hedayati E, Bhoo-Pathy N. , et al. Time-dependent risk and predictors of venous thromboembolism in breast cancer patients: a population-based cohort study. Cancer 2017; 123 (03) 468-475
    CrossrefPubMedGoogle Scholar
  • 15 Chew HK, Wun T, Harvey DJ, Zhou H, White RH. Incidence of venous thromboembolism and the impact on survival in breast cancer patients. J Clin Oncol 2007; 25 (01) 70-76
    CrossrefPubMedGoogle Scholar
  • 16 Ording AG, Nielsen ME, Smith AB, Horváth-Puhó E, Sørensen HT. Venous thromboembolism and effect of comorbidity in bladder cancer: a Danish nationwide cohort study of 13,809 patients diagnosed between 1995 and 2011. Urol Oncol 2016; 34 (07) 292.e1-292.e8
    CrossrefPubMedGoogle Scholar
  • 17 Lund JL, Østgård LS, Prandoni P, Sørensen HT, de Nully Brown P. Incidence, determinants and the transient impact of cancer treatments on venous thromboembolism risk among lymphoma patients in Denmark. Thromb Res 2015; 136 (05) 917-923
    CrossrefPubMedGoogle Scholar
  • 18 Rodriguez AO, Wun T, Chew H, Zhou H, Harvey D, White RH. Venous thromboembolism in ovarian cancer. Gynecol Oncol 2007; 105 (03) 784-790
    CrossrefPubMedGoogle Scholar
  • 19 Sandhu R, Pan CX, Wun T. , et al. The incidence of venous thromboembolism and its effect on survival among patients with primary bladder cancer. Cancer 2010; 116 (11) 2596-2603
    PubMedGoogle Scholar
  • 20 Rodriguez AO, Gonik AM, Zhou H, Leiserowitz GS, White RH. Venous thromboembolism in uterine cancer. Int J Gynecol Cancer 2011; 21 (05) 870-876
    CrossrefPubMedGoogle Scholar
  • 21 Chew HK, Davies AM, Wun T, Harvey D, Zhou H, White RH. The incidence of venous thromboembolism among patients with primary lung cancer. J Thromb Haemost 2008; 6 (04) 601-608
    CrossrefPubMedGoogle Scholar
  • 22 Jensvoll H, Severinsen MT, Hammerstrøm J. , et al. Existing data sources in clinical epidemiology: the Scandinavian Thrombosis and Cancer Cohort. Clin Epidemiol 2015; 7: 401-410
    CrossrefPubMedGoogle Scholar
  • 23 Tjønneland A, Olsen A, Boll K. , et al. Study design, exposure variables, and socioeconomic determinants of participation in Diet, Cancer and Health: a population-based prospective cohort study of 57,053 men and women in Denmark. Scand J Public Health 2007; 35 (04) 432-441
    CrossrefPubMedGoogle Scholar
  • 24 Jacobsen BK, Eggen AE, Mathiesen EB, Wilsgaard T, Njølstad I. Cohort profile: the Tromso Study. Int J Epidemiol 2012; 41 (04) 961-967
    CrossrefPubMedGoogle Scholar
  • 25 Krokstad S, Langhammer A, Hveem K. , et al. Cohort profile: the HUNT Study, Norway. Int J Epidemiol 2013; 42 (04) 968-977
    CrossrefPubMedGoogle Scholar
  • 26 Danish Health Authority. Det moderne Cancerregister – metode og kvalitet. 2009:1–30. Available at: https://sundhedsdatastyrelsen.dk/-/media/sds/filer/registre-og-services/nationale-sundhedsregistre/sygedomme-laegemidler-og-behandlinger/cancerregisteret/det-moderniserede-cancerregister.pdf?la=da . Accessed November 21, 2017
    PubMedGoogle Scholar
  • 27 Kreft registeret. Dokumentasjon av Kreftregisterets variabler. 2015 (versjon 4.1.9.11):1. Available at: https://www.kreftregisteret.no/contentassets/6b389374314344d8a37726aa4d79c732/dokumentasjon_av_variabler-v4.1.pdf . Accessed November 21, 2017
    PubMedGoogle Scholar
  • 28 Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registry--history, content, quality and use. Dan Med Bull 1997; 44 (05) 535-539
    PubMedGoogle Scholar
  • 29 Larsen IK, Småstuen M, Johannesen TB. , et al. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer 2009; 45 (07) 1218-1231
    CrossrefPubMedGoogle Scholar
  • 30 Friis S, Jørgensen T, Mellemkjær L. Validation of the Danish Cancer Registry and Selected Clinical Cancer Databases. Copenhagen, Denmark: Danish Cancer Society; 2012: 1-2
    Google Scholar
  • 31 Walters S, Maringe C, Butler J, Brierley JD, Rachet B, Coleman MP. Comparability of stage data in cancer registries in six countries: lessons from the International Cancer Benchmarking Partnership. Int J Cancer 2013; 132 (03) 676-685
    CrossrefPubMedGoogle Scholar
  • 32 Gade IL, Braekkan SK, Naess IA. , et al. The impact of initial cancer stage on the incidence of venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) Cohort. J Thromb Haemost 2017; 15 (08) 1567-1575
    CrossrefPubMedGoogle Scholar
  • 33 Braekkan SK, Mathiesen EB, Njølstad I, Wilsgaard T, Størmer J, Hansen JB. Mean platelet volume is a risk factor for venous thromboembolism: the Tromsø Study, Tromsø, Norway. J Thromb Haemost 2010; 8 (01) 157-162
    CrossrefPubMedGoogle Scholar
  • 34 Naess IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstrøm J. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost 2007; 5 (04) 692-699
    CrossrefPubMedGoogle Scholar
  • 35 Severinsen MT, Kristensen SR, Overvad K, Dethlefsen C, Tjønneland A, Johnsen SP. Venous thromboembolism discharge diagnoses in the Danish National Patient Registry should be used with caution. J Clin Epidemiol 2010; 63 (02) 223-228
    CrossrefPubMedGoogle Scholar
  • 36 Whittle AM, Allsup DJ, Bailey JR. Chronic lymphocytic leukaemia is a risk factor for venous thromboembolism. Leuk Res 2011; 35 (03) 419-421
    CrossrefPubMedGoogle Scholar
  • 37 Šimkovič M, Vodárek P, Motyčková M. , et al. Venous thromboembolism in patients with chronic lymphocytic leukemia. Thromb Res 2015; 136 (06) 1082-1086
    CrossrefPubMedGoogle Scholar
  • 38 Geddings JE, Mackman N. Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients. Blood 2013; 122 (11) 1873-1880
    CrossrefPubMedGoogle Scholar
  • 39 Ording AG, Horváth-Puhó E, Lash TL. , et al. Prostate cancer, comorbidity, and the risk of venous thromboembolism: a cohort study of 44,035 Danish prostate cancer patients, 1995-2011. Cancer 2015; 121 (20) 3692-3699
    CrossrefPubMedGoogle Scholar
  • 40 De Angelis R, Sant M, Coleman MP. , et al; EUROCARE-5 Working Group. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study. Lancet Oncol 2014; 15 (01) 23-34
    CrossrefPubMedGoogle Scholar